BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25065969)

  • 1. Therapeutic exploitation of necroptosis for cancer therapy.
    Fulda S
    Semin Cell Dev Biol; 2014 Nov; 35():51-6. PubMed ID: 25065969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia.
    Huang X; Xiao F; Li Y; Qian W; Ding W; Ye X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):310. PubMed ID: 30541583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting apoptosis for anticancer therapy.
    Fulda S
    Semin Cancer Biol; 2015 Apr; 31():84-8. PubMed ID: 24859747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necroptosis: a novel therapeutic target for glioblastoma.
    Jiang YG; Peng Y; Koussougbo KS
    Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of necroptosis in normal and cancer cells.
    Fulda S
    Cancer Biol Ther; 2013 Nov; 14(11):999-1004. PubMed ID: 24025353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
    Hu X; Xuan Y
    Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of necroptosis in cancer.
    Lalaoui N; Brumatti G
    Immunol Cell Biol; 2017 Feb; 95(2):137-145. PubMed ID: 27922620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLIP: molecular switch between apoptosis and necroptosis.
    Gong J; Kumar SA; Graham G; Kumar AP
    Mol Carcinog; 2014 Sep; 53(9):675-85. PubMed ID: 23625539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical regulation of signaling pathways to programmed necrosis.
    Bae JH; Shim JH; Cho YS
    Arch Pharm Res; 2014 Jun; 37(6):689-97. PubMed ID: 24715577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy.
    Schilling R; Geserick P; Leverkus M
    Methods Enzymol; 2014; 545():83-102. PubMed ID: 25065887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using drugs to target necroptosis: dual roles in disease therapy.
    Wang Z; Guo LM; Zhou HK; Qu HK; Wang SC; Liu FX; Chen D; Huang JF; Xiong K
    Histol Histopathol; 2018 Aug; 33(8):773-789. PubMed ID: 29393502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross talk between cell death regulation and metabolism.
    Fulda S
    Methods Enzymol; 2014; 542():81-90. PubMed ID: 24862261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological mechanisms of death resistance in colorectal carcinoma.
    Huang CY; Yu LC
    World J Gastroenterol; 2015 Nov; 21(41):11777-92. PubMed ID: 26557002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.
    Tan CP; Lu YY; Ji LN; Mao ZW
    Metallomics; 2014 May; 6(5):978-95. PubMed ID: 24668273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted manipulation of apoptosis in cancer treatment.
    Call JA; Eckhardt SG; Camidge DR
    Lancet Oncol; 2008 Oct; 9(10):1002-11. PubMed ID: 18760670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer therapy in the necroptosis era.
    Su Z; Yang Z; Xie L; DeWitt JP; Chen Y
    Cell Death Differ; 2016 May; 23(5):748-56. PubMed ID: 26915291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents.
    Kopalli SR; Kang TB; Koppula S
    Expert Opin Ther Pat; 2016 Nov; 26(11):1239-1256. PubMed ID: 27568917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of apoptosis signaling for cancer therapy.
    Fulda S; Debatin KM
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting IAP proteins in combination with radiotherapy.
    Fulda S
    Radiat Oncol; 2015 Apr; 10():105. PubMed ID: 25927408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.